An2therapeutics.com

Keyword Suggestion

An2 therapeutics

An2 therapeutics stock

An2 therapeutics news

An2 therapeutics inc. antx

An2 therapeutics stock price

An2 therapeutics ipo

An2 therapeutics jobs

An2 therapeutics linkedin

An2 therapeutics headquarters

An2 therapeutics swot analysis

An2 therapeutics stock price yahoo

An2therapeutics.com lookup results from whois.godaddy.com server:

Network

Owner

Technical support

Abuse

Domain Provider	Number Of Domains
godaddy.com	286730
namecheap.com	101387
networksolutions.com	69118
tucows.com	52617
publicdomainregistry.com	39120
whois.godaddy.com	32793
enomdomains.com	23825
namesilo.com	21429
domains.google.com	21384
cloudflare.com	20573
gmo.jp	18110
name.com	17601
fastdomain.com	14708
register.com	13495
net.cn	12481
ionos.com	12416
ovh.com	12416
gandi.net	12305
registrar.amazon.com	12111

Host Informations

Check all domain's dns records

See Web Sites Hosted on 54.176.110.96

Fetching Web Sites Hosted

Site Inspections

Port Scanner (IP: 54.176.110.96)

› Ftp: 21

› Ssh: 22

› Telnet: 23

› Smtp: 25

› Dns: 53

› Http: 80

› Pop3: 110

› Portmapper, rpcbind: 111

› Microsoft RPC services: 135

› Netbios: 139

› Imap: 143

› Ldap: 389

› Https: 443

› SMB directly over IP: 445

› Msa-outlook: 587

› IIS, NFS, or listener RFS remote_file_sharing: 1025

› Lotus notes: 1352

› Sql server: 1433

› Point-to-point tunnelling protocol: 1723

› My sql: 3306

› Remote desktop: 3389

› Session Initiation Protocol (SIP): 5060

› Virtual Network Computer display: 5900

› X Window server: 6001

› Webcache: 8080

Spam Check (IP: 54.176.110.96)

› Dnsbl-1.uceprotect.net:

› Dnsbl-2.uceprotect.net:

› Dnsbl-3.uceprotect.net:

› Dnsbl.dronebl.org:

› Dnsbl.sorbs.net:

› Spam.dnsbl.sorbs.net:

› Bl.spamcop.net:

› Recent.dnsbl.sorbs.net:

› All.spamrats.com:

› B.barracudacentral.org:

› Bl.blocklist.de:

› Bl.emailbasura.org:

› Bl.mailspike.org:

› Bl.spamcop.net:

› Cblplus.anti-spam.org.cn:

› Dnsbl.anticaptcha.net:

› Ip.v4bl.org:

› Fnrbl.fast.net:

› Dnsrbl.swinog.ch:

› Mail-abuse.blacklist.jippg.org:

› Singlebl.spamgrouper.com:

› Spam.abuse.ch:

› Spamsources.fabel.dk:

› Virbl.dnsbl.bit.nl:

› Cbl.abuseat.org:

› Dnsbl.justspam.org:

› Zen.spamhaus.org:

Email address with an2therapeutics.com

Found 2 emails of this domain
1. [email protected]
2. [email protected]

Recent Searched Sites

› Tracextech.com (16 seconds ago) / US

› Urman.pro (17 seconds ago) / RU

› Elitedentalanddenture.com (37 seconds ago) / US

› Creditkins.ru (15 seconds ago) / UA

› Tl.is (12 seconds ago) / US

› Inagaki-cl.com (22 seconds ago) / JP

› E-ryowa.com (18 seconds ago) / JP

› Aqurus.ca (26 seconds ago) / CA

› Puentenet-usa.com (37 seconds ago) / US

› 5toft8or7on8tt.com (7 seconds ago) / US

› Amyshine.net (5 seconds ago) / US

› Cwalakestreet.com (12 seconds ago) / US

› Pinetreepoetry.com (2 seconds ago) / US

› Frayt.com (6 seconds ago) / US

› Mrjoshi.co.uk (10 seconds ago) / US

› Elwoodclothing.com (29 seconds ago) / CA

› An2therapeutics.com (0 seconds ago) / US

› Grand-hyatt.santiago-chile-hotels.net (4 seconds ago) / CA

› Litclub-phoenix.ru (4 seconds ago) / RU

› Hikaririders.com (38 seconds ago) / US

List of our tools

Emails by domain

Mobile Friendly Check

Page Speed Check

DNS Lookup

Ports Scan

Sites on host

Sitemap Generator

Websites Listing

We found Websites Listing below when search with an2therapeutics.com on Search Engine

Leadership | Board of Directors | Partners | AN2 Therapeutics

In addition to being the Founder, President and CEO of AN2 Therapeutics, Mr. Easom also serves on the Board of Directors of AN2 Therapeutics. Mr. Easom serves on the Board of Directors for the Chagas Disease Foundation, Resilient Biotics, and is an advisor for the California Life Sciences Institute. Previously, Mr. Easom spent 9 years at Anacor ...

An2therapeutics.com

AN2 Therapeutics | LinkedIn

AN2 Therapeutics, Inc. is a biopharmaceutical company dedicated to developing therapies to treat rare, chronic, and serious infectious diseases in …

Linkedin.com

Antag Therapeutics – Therapeutic peptides for the …

Antag Therapeutics is based on years of collaborative research from the University of Copenhagen with the focus on novel treatments for dietary-related metabolic diseases. The research teams of professor Mette Rosenkilde and professor Jens Juul Holst have discovered a naturally occurring peptide that is being investigated in several human studies.

Antagtherapeutics.com

an2 therapeutics - iStock

Go to an2 therapeutics. You are about to leave and go to an2 therapeutics Confirm. People Also Ask. rfacu ipo wlds ipo rvsn marketwatch gdstu ipo gns stock gns ipo akan ipo. Popular Search Web Page. AN2 Therapeutics, Inc. (ANTX) Stock Price, News, Quote & History Find the latest AN2 Therapeutics, Inc. (ANTX) stock quote, history, news and other vital information to …

Istock.tw

Home | A2 Bio Therapeutics

2022-03-04 · A2 Bio proprietary Tmod™ platform has the ability to absolutely distinguish tumor from normal cells. This is accomplished by integrating multiple signals, overcoming the limits of conventional single-target therapies and by exploiting common, specific gene losses only found in tumor cells. Addressing the fundamental challenge that limits the ...

A2bio.com

An2 Therapeutics, Inc. Company Profile | Menlo Park, CA

Company Description: An2 Therapeutics, Inc. is located in Menlo Park, CA, United States and is part of the Scientific Research and Development Services Industry. An2 Therapeutics, Inc. has 23 total employees across all of its locations and generates $1.07 million in sales (USD). (Sales figure is modelled).

Dnb.com

Home - Fate Therapeutics

Fatetherapeutics.com

AN2 Therapeutics Company Profile: Stock Performance & Earnings …

AN2 Therapeutics General Information. Description. AN2 Therapeutics Inc is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. The initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial ...

Pitchbook.com

AN2 Therapeutics, Inc. Software Purchases and Digital …

Discover the latest ERP, HCM, CRM, Procurement software purchases and digital transformation initiatives being undertaken by AN2 Therapeutics, Inc. …

Appsruntheworld.com

AN2 Therapeutics Announces Pricing of Upsized Initial Public …

2022-03-25 · AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. AN2 is developing epetraborole ...

Finance.yahoo.com

AN2 Therapeutics, Inc Dividends – NASDAQ:ANTX – TradingView

Watch AN2 Therapeutics, Inc dividends key stats, including dividend yield, payout ratio and history — let the numbers help you decide if it’s a reliable stock. Search. Products; Community; Markets; Brokers; More; Get started. Markets US Stocks Health Technology Biotechnology ANTX Financials. AN2 Therapeutics, Inc ANTX NASDAQ. ANTX. AN2 Therapeutics, Inc NASDAQ. …

Tradingview.com

AN2 Therapeutics’ IPO raises $69M to take antibiotic from Pfizer …

2022-03-25 · When AN2 Therapeutics set financial terms for the stock offering earlier this week, the company planned to offer 4 million shares in the range of $14 to $16 each. AN2 was able to boost the size of ...

Medcitynews.com

AN2 Therapeutics Inc. | AN2 THERAPEUTICS, INC.

2019-03-15 · AN2 Therapeutics Inc. DUNS 080615335 / 08-061-5335 AN2 THERAPEUTICS, INC. NCAGE Code: 822Z2. AN2 THERAPEUTICS INC.!DIV AN2 THERAPEUTICS. CAGE Code: 822Z2. AN2 THERAPEUTICS, INC. DUNS: 080615335. AN2 Therapeutics Inc. S.A.M. Registration: 822Z2 [80615335] AN2 THERAPEUTICS, INC. Company Details. Identification, …

Cage.report

AN2 Therapeutics, Inc. (ANTX) Stock Price, Quote & News | Stock …

2 days ago · AN2 Therapeutics is a clinical-stage biopharmaceutical company developing treatments for rare, chronic, and serious infectious diseases with high unmet needs. Our initial product candidate is epetraborole, a once-daily oral treatment for patients with chronic non-tuberculous mycobacterial, or NTM, lung disease. Epetraborole has broad spectrum …

Stockanalysis.com

Bay Area's first stock debut in nearly 2 months, by AN2 …

2022-03-25 · AN2 Therapeutics Inc. on Thursday broke a nearly two-month drought on initial public offerings from the Bay Area. But experts caution not to expect a flood of other offerings following close behind.

Bizjournals.com

AN2 Therapeutics Will Trade Friday. Now There Are 2 March IPOs.

2022-03-24 · AN2 Therapeutics is slated to price its deal later Thursday and trade Friday, a person familiar with the situation said. AN2 is selling 4 million shares at $14 to $16 each, according to a ...

Barrons.com

IPO Update: AN2 Therapeutics Seeks $60 Million U.S. IPO

2022-03-22 · AN2 Therapeutics has filed proposed terms for a $60 million IPO. The firm is advancing treatments for chronic non-tuberculous mycobacterial, or NTM, lung disease. ANTX is a mid-stage biopharma ...

Seekingalpha.com

AN2 Therapeutics Closed $80 Million Series B Financing to …

2022-01-07 · AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet need. AN2 ...

Finance.yahoo.com

AN2 Therapeutics Announces Pricing of Upsized Initial

Globenewswire.com

2022-01-07 | NDAQ:CALA | Press Release - stockhouse

2022-01-07 · About AN2 Therapeutics, Inc. AN2 Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel therapies to treat rare, chronic, and serious infectious diseases in areas of high unmet need. AN2 is developing epetraborole, a once-daily oral investigational treatment for patients with chronic non-tuberculous ...

Stockhouse.com

Domains Expiration Date Updated

Site	Provider	Expiration Date
thenativessamui.com	publicdomainregistry.com	-2 Years, -168 Days
racermec.com	tucows.com	-2 Years, -89 Days
devotedtodog.com	godaddy.com	-2 Years, -85 Days
gotavision.org	namecheap.com	-1 Years, -322 Days
sexub.com	publicdomainregistry.com	-2 Years, -166 Days
timberpines.com	networksolutions.com	2 Years, 153 Days
amblehimalaya.com	godaddy.com	329 Days
flynorse.com	domainnameshop.com	-1 Years, -187 Days
limda.net	publicdomainregistry.com	1 Year, 290 Days
tmuna.co	whois.godaddy.com	247 Days

Browser All